🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

7,888 results for “1” Clear

  1. Brilique 90 mg film-coated tablets, Clopidogrel Medreg 75 mg filmom obalené tablety

    Disc Medicine

    Patients with coronary artery disease and an indication for PCI

    approved small molecule active

    1 trial

  2. Brodalumab 70 mg, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP, without the active substance., Kyntheum 210 mg solution for injection in pre-filled syringe

    LEO Pharma A/S

    Moderate-to-severe plaque psoriasis and a body weight ≥120 kg.

    approved small molecule active

    1 trial

  3. C1 inhibitor (human) [C1 INH]

    Takeda

    Hereditary Angioedema

    approved mab completed

    1 trial

  4. CAPECITABINE, CALCIUM FOLINATE, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Calciumfolinat Kabi 10 mg/ml Injektions-/Infusionslösung, FLUOROURACIL, Lenvatinib, Lenvatinib, Calciumfolinat-GRY® 100 mg/10 ml Injektionslösung, OXALIPLATIN, Lenvatinib, CALCIUM LEVOFOLINATE , CAPECITABINE

    Merck Sharp and Dohme

    Advanced/Metastatic Gastroesophageal Adenocarcinoma

    approved small molecule active

    1 trial

  5. CAPVAXIVE solution for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (21-valent), Prevenar 20 suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)

    Disc Medicine

    Asplenia

    approved small molecule active

    1 trial

  6. CARBOPLATIN, PACLITAXEL, DOCETAXEL, VINORELBINE TARTRATE, CISPLATIN, PEMETREXED

    CERO THERAPEUTICS HOLDINGS, INC.

    Completely resected stage I or IIA non-squamous non-small cell lung cancer (NSCLC)

    approved small molecule active

    1 trial

  7. CEFAZOLIN

    Pari Pharma GmbH

    Infection prophylaxis

    approved small molecule active

    1 trial

  8. CELLULOSE, MICROCRYSTALLINE, Diltiazem HCl Auro retard 120 mg, tabletten met gereguleerde afgifte

    Disc Medicine

    Angina

    approved small molecule active

    1 trial

  9. CELLULOSE, MICROCRYSTALLINE, YOCORAL 5 mg tabletten, Hydrocortison Teva 10 mg, filmomhulde tabletten

    Disc Medicine

    Mimic an acute stress response in humans.

    approved small molecule active

    1 trial

  10. CERITINIB

    Novartis Pharmaceuticals

    non small cell lung cancer

    approved small molecule active

    1 trial

  11. CHLORURE DE SODIUM 0,9 % VIAFLO, solution pour perfusion, Avastin 25 mg/ml concentrate for solution for infusion.

    Tour Hekla

    1st line treatment for unresectable metastatic colorectal cancer

    approved small molecule active

    1 trial

  12. COBICISTAT , OLAPARIB

    Disc Medicine

    Cancer

    approved small molecule active

    1 trial

  13. COMBINATIONS

    Disc Medicine

    muscle protein turnover hemodialysis

    approved small molecule active

    1 trial

  14. COVAX

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    approved mab active

    1 trial

  15. COVID-19 Vaccine (Vero cell), Inactivated

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  16. CYP2C19 genotyping

    Vera Therapeutics

    Myocardial Infarction

    approved gene therapy completed

    1 trial

  17. Calquence 100 mg film-coated tablets, Calquence 100 mg film-coated tablets

    AstraZeneca AB

    Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment

    approved small molecule active

    1 trial

  18. Capsules with microcrystalline cellulose, Colchicine Teva 0,5 mg, tabletten

    Disc Medicine

    Type 1 Diabetes

    approved small molecule active

    1 trial

  19. Ceftriaxon Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie, Ceftazidim Fresenius Kabi 500 mg poeder voor oplossing voor injectie, Amoxicilline/Clavulaanzuur Sandoz 2000 mg/200 mg i.v., poeder voor oplossing voor intraveneuze infusie, Cefuroxim Hikma 1500 mg poeder voor oplossing voor injectie of infusie, Meropenem CF 1000 mg, poeder voor oplossing voor injectie of infusie, Meropenem Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie, Piperacilline/Tazobactam Fresenius Kabi 2

    Disc Medicine

    Sepsis

    approved small molecule active

    1 trial

  20. Cisplatin Accord Healthcare 1 mg/ml concentraat voor oplossing voor infusie

    Disc Medicine

    Locally advanced head and neck squamous cell carcinoma

    approved small molecule active

    1 trial

  21. Comirnaty 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, Spikevax 0.2 mg/mL dispersion for injection COVID-19 mRNA Vaccine, EVUSHELD 150 mg + 150 mg solution for injection, Xevudy 500 mg concentrate for solution for infusion, Nuvaxovid dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)

    The George Institute

    Covid-19 infection

    approved small molecule active

    1 trial

  22. Commercial Hylenex® recombinant (hyaluronidase human injection)

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    approved small molecule completed

    1 trial

  23. Concomitant administration of EV71 vaccine with EPI vaccines

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  24. Concomitant administration of EV71vaccine with EPI vaccines

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources